Oculogyric crisis due to aripiprazole ingestion as a suicide attempt: a case report - Bafarat A, Alaseeri B, Labban SA, Morya RE.
Oculogyric crisis (OGC) is a rare type of acute dystonia characterized by spasmodic upward deviation of the eyes lasting for a few minutes to several hours. It is commonly seen with the administration of first-generation antipsychotics and rarely reported ... (Source: SafetyLit)
Source: SafetyLit - December 11, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
MDMA Cured Extremism? Abilify Pain Cream Scheme; Ritalin's Opposite Effect in Some
(MedPage Today) -- After the former leader of a white nationalist group took a single dose of MDMA during a psychiatric clinical study, he revised his extremist views. (BBC)
Is laughter the best medicine? A meta-analysis of 29 studies found that... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - June 21, 2023 Category: Psychiatry Source Type: news
FDA OKs New LAIs for Schizophrenia; Largest Psych Fellow Class; Quelling Loneliness
(MedPage Today) -- The FDA approved a long-acting injection of risperidone (Uzedy) for the treatment of schizophrenia in adults, Teva and MedinCell announced.
And the agency approved a long-acting injectable version of aripiprazole (Abilify Asimtufii... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - May 3, 2023 Category: Psychiatry Source Type: news
FDA Approves Abilify Asimtufii (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults
April 28, 2023 -- Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Abilify Asimtufii® (aripiprazole)... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 28, 2023 Category: Drugs & Pharmacology Source Type: news
Relieving treatment-resistant depression in older adults
For older adults whose depression persisted while taking an antidepressant, adding aripiprazole had greater benefits than switching to another antidepressant. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - April 11, 2023 Category: Consumer Health News Source Type: news
Patients given aripiprazole ‘should be told of gambling addiction risks’
Expert urges greater monitoring of side-effect of drug used to treat depression, psychosis and schizophreniaPatients who are prescribed a common antipsychotic used to treat depression, bipolar disorder, psychosis and schizophrenia need to be told there is a risk they could develop a gambling addiction, an expert has warned.The National Problem Gambling Clinic has observed growing numbers of patients who have developed a gambling addiction after starting to take aripiprazole. Some patients have lost huge sums of money as a result and seen their relationships fall apart.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 26, 2023 Category: Science Authors: Rachel Hall Tags: Drugs Gambling UK news Health Mental health Science Society Source Type: news
Add-on Antipsychotic Tops Switching Meds for Resistant Depression Add-on Antipsychotic Tops Switching Meds for Resistant Depression
For older patients with resistant depression who fail to respond to antidepressants, the addition of atypical antipsychotic aripiprazole is superior to switching antidepressants, new research suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 6, 2023 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Antidepressant Augmentation Examined in Seniors With Depression
MONDAY, March 6, 2023 -- Augmentation of existing antidepressants with aripiprazole improves well-being among older adults with treatment-resistant depression, according to a study published online March 3 in the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 6, 2023 Category: Pharmaceuticals Source Type: news
Adding Abilify Eased Tough-to-Treat Depression in Seniors
(MedPage Today) -- Adding another antidepressant to the mix was more helpful than switching agents in older adults with treatment-resistant depression, a two-step, open-label trial suggested.
In the first step of the study which included 619 adults... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 3, 2023 Category: Primary Care Source Type: news
Rainbow Fentanyl Warning; In Utero Hurricane Trauma; Aripiprazole LAI Heads to FDA
(MedPage Today) -- Following a recent Drug Enforcement Administration warning, schools are notifying students about "rainbow" fentanyl that looks like brightly colored candy. (CNN)
Cognitive belief updating tended to be optimistic as soon as 4... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 28, 2022 Category: Psychiatry Source Type: news
A Growing Number of Young People Are Attempting Suicide by Self-Poisoning
Suicides among young people have been on the rise for a long time. Among 10 to 24 year olds, overall rates of deaths by suicide in the U.S. increased 57% from 2000 to 2018, according to federal data. Now, a new study published in the journal Clinical Toxicology has looked more closely at a particular method of attempted suicide—self-poisoning—and turned up some disturbing results: From 2015 to 2020, suicide attempts by ingesting toxic substances or overdosing on medications soared by 26% among people ages 6 to 19.
[time-brightcove not-tgx=”true”]
The research, led by Dr. Jennifer Ross, a medical tox...
Source: TIME: Health - June 1, 2022 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized healthscienceclimate Mental Health Source Type: news
No significant change in total healthcare costs with aripiprazole lauroxil
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2021 Category: Drugs & Pharmacology Source Type: news
Novel model shows LAI aripiprazole may be cost effective
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2021 Category: Drugs & Pharmacology Source Type: news
aripiprazole (Abilify)
Title: aripiprazole (Abilify)Category: MedicationsCreated: 2/17/2004 12:00:00 AMLast Editorial Review: 8/6/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 6, 2021 Category: Drugs & Pharmacology Source Type: news
Spectrum Reporting Prompts New Review of Common Drug
The review of more than two dozen studies finds aripiprazole has side effects and does not change core autism features, but parents report improvements in self-injury, tantrums, and other challenging... (Source: The Scientist)
Source: The Scientist - February 11, 2021 Category: Science Tags: News & Opinion Source Type: news
